Tapewire

NYSE · USD

KEY

KEYCORP /NEW/

Export transactions ↓
Tapewire entity
3220
SEC CIK
0000091576
Parsed reports
868

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202601
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2025 Filed May 19, 2025 20:45 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000075 · wk-form4_1747687494.xml · derivative · entry 2

Hipple Richard J · CIK 0001311365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,905

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:43 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000074 · wk-form4_1747687399.xml · derivative · entry 2

Highsmith Carlton L · CIK 0001379848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,905

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:42 UTC
Hayes RobinDirector
GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000073 · wk-form4_1747687326.xml · derivative · entry 2

Hayes Robin · CIK 0001443147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,627

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:32 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000071 · wk-form4_1747686727.xml · derivative · entry 2

Gile Elizabeth R. · CIK 0001487311 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,443

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2030.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2030.

F4 · balance_after: Includes approximately 1,480 dividend-equivalent Deferred Shares accrued in March 2025.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:30 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000070 · wk-form4_1747686637.xml · derivative · entry 2

Dallas H James · CIK 0001324953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,905

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:28 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000069 · wk-form4_1747686507.xml · derivative · entry 2

CUTLER ALEXANDER M · CIK 0001188585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,795

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2028.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2028.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:27 UTC GrantDeferred Shares · Derivative 8,798 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000068 · wk-form4_1747686422.xml · derivative · entry 2

Allard Jacqui · CIK 0002050454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,798

Underlying: Common Shares · 8,798 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share.

F3 · price: The Deferred Shares were awarded under the Deferred Share Plan.

F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until October 1, 2029.

F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until October 1, 2029.

Read SEC document
May 13, 2025 Filed May 14, 2025 21:04 UTC SaleCommon Shares 5,000 $16.60 $83,000.00
Disclosure

SEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 3

Highsmith Carlton L · CIK 0001379848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,177

Read SEC document
May 12, 2025 Filed May 14, 2025 21:07 UTC Exercise / conversionDeferred Shares · Derivative 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · derivative · entry 3

Hipple Richard J · CIK 0001311365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,107

Underlying: Common Shares · 8,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F3 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:07 UTC Disposition to issuerCommon Shares 4,312 $14.70 $63,386.40
Disclosure

SEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · nonDerivative · entry 2

Hipple Richard J · CIK 0001311365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,420

Read SEC document
May 12, 2025 Filed May 14, 2025 21:07 UTC Exercise / conversionCommon Shares 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · nonDerivative · entry 1

Hipple Richard J · CIK 0001311365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F2 · balance_after: Includes approximately 1,628 common shares acquired through dividend reinvestments between June 2024 and March 2025.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:04 UTC Exercise / conversionDeferred Shares · Derivative 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · derivative · entry 4

Highsmith Carlton L · CIK 0001379848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,107

Underlying: Common Shares · 8,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F2 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:04 UTC Disposition to issuerCommon Shares 4,312 $14.70 $63,386.40
Disclosure

SEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 2

Highsmith Carlton L · CIK 0001379848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,178

Read SEC document
May 12, 2025 Filed May 14, 2025 21:04 UTC Exercise / conversionCommon Shares 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 1

Highsmith Carlton L · CIK 0001379848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:03 UTC
Hayes RobinDirector
Exercise / conversionDeferred Shares · Derivative 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · derivative · entry 3

Hayes Robin · CIK 0001443147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,829

Underlying: Common Shares · 8,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:03 UTC
Hayes RobinDirector
Disposition to issuerCommon Shares 4,312 $14.70 $63,386.40
Disclosure

SEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · nonDerivative · entry 2

Hayes Robin · CIK 0001443147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,549

Read SEC document
May 12, 2025 Filed May 14, 2025 21:03 UTC
Hayes RobinDirector
Exercise / conversionCommon Shares 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · nonDerivative · entry 1

Hayes Robin · CIK 0001443147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:01 UTC Exercise / conversionDeferred Shares · Derivative 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · derivative · entry 3

Dallas H James · CIK 0001324953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,107

Underlying: Common Shares · 8,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

F2 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:01 UTC Disposition to issuerCommon Shares 4,312 $14.70 $63,386.40
Disclosure

SEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · nonDerivative · entry 2

Dallas H James · CIK 0001324953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,710

Read SEC document
May 12, 2025 Filed May 14, 2025 21:01 UTC Exercise / conversionCommon Shares 8,626 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · nonDerivative · entry 1

Dallas H James · CIK 0001324953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares.

Read SEC document
April 22, 2025 Filed Apr 23, 2025 21:21 UTC PurchaseCommon Shares 180 $14.03 $2,525.40
Disclosure

SEC source: 0000091576-25-000054 · wk-form4_1745443289.xml · nonDerivative · entry 1

Allard Jacqui · CIK 0002050454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180

Read SEC document
April 21, 2025 Filed Apr 23, 2025 21:19 UTC PurchaseCommon Shares 750 $13.84 $10,380.00
Disclosure

SEC source: 0000091576-25-000053 · wk-form4_1745443148.xml · nonDerivative · entry 1

Tobin Richard J · CIK 0001681915 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

Read SEC document
April 21, 2025 Filed Apr 23, 2025 21:17 UTC PurchaseCommon Shares 100 $13.87 $1,387.00
Disclosure

SEC source: 0000091576-25-000052 · wk-form4_1745443032.xml · nonDerivative · entry 1

Khanna Somesh · CIK 0002050456 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100

Read SEC document
April 21, 2025 Filed Apr 23, 2025 21:15 UTC
Ramani MohitChief Risk Officer
PurchaseCommon Shares 10,000 $13.75 $137,500.00
Disclosure

SEC source: 0000091576-25-000051 · wk-form4_1745442933.xml · nonDerivative · entry 1

Ramani Mohit · CIK 0002053125 · Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.75 to $13.76.

F2 · price: The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:33 UTC GrantDeferred Shares · Derivative 1,876 $15.99 $29,997.24
Disclosure

SEC source: 0000091576-25-000047 · wk-form4_1743626029.xml · derivative · entry 2

Tobin Richard J · CIK 0001681915 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,695

Underlying: Common Shares · 1,876 shares

Expires not disclosed

F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.

F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.

F3 · balance_after: On October 2, 2024, the Reporting Person filed a Form 4 which inadvertently omitted the acquisition of 224 additional Deferred Shares. These additional Deferred Shares, acquired on September 30, 2024, are included in the total reported in this Form 4.

F4 · balance_after: Includes approximately 765 dividend-equivalent deferred shares accrued under the Deferred Share Plan between December 2024 and March 2025.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:32 UTC
VASOS TODD JDirector
GrantDeferred Shares · Derivative 2,032 $15.99 $32,491.68
Disclosure

SEC source: 0000091576-25-000046 · wk-form4_1743625913.xml · derivative · entry 2

VASOS TODD J · CIK 0001243183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,666

Underlying: Common Shares · 2,032 shares

Expires not disclosed

F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.

F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.

F3 · balance_after: Includes approximately 731 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:24 UTC GrantDeferred Shares · Derivative 1,876 $15.99 $29,997.24
Disclosure

SEC source: 0000091576-25-000045 · wk-form4_1743625492.xml · derivative · entry 2

Rankin Devina A · CIK 0001557267 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,239

Underlying: Common Shares · 1,876 shares

Expires not disclosed

F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2031, or the death of the participant.

F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2031, or the death of the participant.

F3 · balance_after: Includes approximately 792 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:22 UTC
Hayes RobinDirector
GrantDeferred Shares · Derivative 1,876 $15.99 $29,997.24
Disclosure

SEC source: 0000091576-25-000044 · wk-form4_1743625345.xml · derivative · entry 2

Hayes Robin · CIK 0001443147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,455

Underlying: Common Shares · 1,876 shares

Expires not disclosed

F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2028, or the death of the participant.

F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2028, or the death of the participant.

F3 · balance_after: Includes approximately 704 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:20 UTC GrantDeferred Shares · Derivative 1,407 $15.99 $22,497.93
Disclosure

SEC source: 0000091576-25-000043 · wk-form4_1743625235.xml · derivative · entry 2

CUTLER ALEXANDER M · CIK 0001188585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,997

Underlying: Common Shares · 1,407 shares

Expires not disclosed

F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant.

F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant.

F3 · balance_after: Includes approximately 705 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Exercise / conversionRestricted Stock Units · Derivative 39,352 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 11

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,054

Underlying: Common Shares · 39,352 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F13 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F13 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F14 · balance_after: Includes approximately 8,154 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Exercise / conversionRestricted Stock Units · Derivative 30,978 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 10

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,955

Underlying: Common Shares · 30,978 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F11 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F11 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F12 · balance_after: Includes approximately 4,814 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Exercise / conversionRestricted Stock Units · Derivative 24,558 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 9

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,558

Underlying: Common Shares · 24,558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F9 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F9 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F10 · balance_after: Includes approximately 2,544 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Exercise / conversionRestricted Stock Units · Derivative 20,626 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 8

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 20,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F7 · derivative.exercise_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments beginning on February 17, 2022.

F7 · derivative.expiration_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments beginning on February 17, 2022.

F8 · derivative.underlying_shares: Includes approximately 1,068 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
GrantOption to Buy · Derivative 139,959 $0.00 Strike: $19.49 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 7

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,959

Underlying: Common Shares · 139,959 shares

Expires 2035-02-17

F6 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
GrantRestricted Stock Units · Derivative 116,817 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 6

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,817

Underlying: Common Shares · 116,817 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F5 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

F5 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Tax withholdingCommon Shares 45,559 $17.72 $807,305.48
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · nonDerivative · entry 2

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 869,721

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:32 UTC
Gorman Christopher M.Director · Chairman and CEO
Exercise / conversionCommon Shares 115,514 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · nonDerivative · entry 1

Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 915,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F2 · balance_after: Includes approximately 463 common shares acquired under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan since March 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 8,433 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 8

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,296

Underlying: Common Shares · 8,433 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F10 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F10 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F11 · balance_after: Includes approximately 1,747 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 5,311 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 7

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,619

Underlying: Common Shares · 5,311 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F8 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F8 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F9 · balance_after: Includes approximately 825 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 3,410 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 6

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,410

Underlying: Common Shares · 3,410 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F6 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F6 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F7 · balance_after: Includes approximately 353 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 4,316 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 5

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 4,316 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F4 · derivative.exercise_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments. The final installment vested on February 17, 2025.

F4 · derivative.expiration_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments. The final installment vested on February 17, 2025.

F5 · derivative.underlying_shares: Includes approximately 224 dividend-equivalent restricted stock units accrued between March and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
GrantOption to Buy · Derivative 40,567 $0.00 Strike: $19.49 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 4

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,567

Underlying: Common Shares · 40,567 shares

Expires 2035-02-17

F3 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
GrantRestricted Stock Units · Derivative 33,860 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 3

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,860

Underlying: Common Shares · 33,860 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F2 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

F2 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Tax withholdingCommon Shares 6,758 $17.72 $119,751.76
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · nonDerivative · entry 2

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,344

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:29 UTC
Khayat Clark HChief Financial Officer
Exercise / conversionCommon Shares 21,470 Not disclosed Not disclosed
Disclosure

SEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · nonDerivative · entry 1

Khayat Clark H · CIK 0001342543 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:30 UTC
Ramani MohitChief Risk Officer
GrantOption to Buy · Derivative 26,369 $0.00 Strike: $19.49 $0.00
Disclosure

SEC source: 0000091576-25-000031 · wk-form4_1740000633.xml · derivative · entry 3

Ramani Mohit · CIK 0002053125 · Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,369

Underlying: Common Shares · 26,369 shares

Expires 2035-02-17

F3 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:30 UTC
Ramani MohitChief Risk Officer
GrantRestricted Stock Units · Derivative 22,009 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000031 · wk-form4_1740000633.xml · derivative · entry 2

Ramani Mohit · CIK 0002053125 · Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,009

Underlying: Common Shares · 22,009 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F2 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

F2 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:26 UTC
Gilbert Stacy LChief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 1,406 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 8

Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,215

Underlying: Common Shares · 1,406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F10 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F10 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

F11 · balance_after: Includes approximately 216 dividend-equivalent restricted stock units accrued between June and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:26 UTC
Gilbert Stacy LChief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 753 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 7

Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,504

Underlying: Common Shares · 753 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F8 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F8 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

F9 · balance_after: Includes approximately 87 dividend-equivalent restricted stock units accrued between June and December 2024.

Read SEC document
February 17, 2025 Filed Feb 19, 2025 21:26 UTC
Gilbert Stacy LChief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 443 $0.00 $0.00
Disclosure

SEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 6

Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443

Underlying: Common Shares · 443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

F6 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F6 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

F7 · balance_after: Includes approximately 34 dividend-equivalent restricted stock units accrued between June and December 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.